The Committee on Mutagenicity (COM) has published its conclusions on Cell Transformation Assays (CTAs). Briefly, these are:

  • Syrian hamster embryo (SHE) CTAs are widely used but do not discriminate between genotoxic and non-genotoxic carcinogens
  • the available evidence is not sufficient to recommend routine regulatory use of the SHE (pH 6.7 or pH 7.0), BALB/c 3T3 or Bhas42 CTAs
  • future validation of these assays will require the use of a wide range of carcinogens and non-carcinogens, the development of objective biological markers of cell transformation, quality control procedures for assessment of subjective morphology assessments of transformed colonies or foci and a greater understanding of the molecular mechanism(s) involved in cell transformation

UK Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment.

Statement on Cell Transformation Assays. Referral, COM/12/S4, October 2012.

http://www.iacom.org.uk/statements/documents/COM12S4-CellTransformationAssayStatementfinalforinternet_000.pdf

 

The above item was taken from the December 2012 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here for more details).

News Home Guest Write For Us? Contact Us